Anton Rets
No Rating Available
(Learn About Our Rating System)

Anton Rets, MD, PhD

Languages spoken: English, Russian

Dr. Rets is an associate professor of pathology at the University of Utah School of Medicine. He received his MD and PhD at Perm State Academy of Medicine in Russia. He served as an anatomical and clinical pathology resident at State University of New York Health Science Center at Brooklyn and a hematopathology fellow at the University of Utah School of Medicine. Dr. Rets is board certified in hematopathology, anatomic pathology, and clinical pathology. He is also a member of several professional societies, including the College of American Pathologists and the American Society for Clinical Pathology. Dr. Rets’ professional interests include red blood cell disorders, non-neoplastic hematology, and myeloproliferative neoplasms.

Specialties

  • Hematopathology

Board Certification

American Board of Pathology (Anatomic & Clinical)
American Board of Pathology (Sub: Hematopathology)

Board Certification and Academic Information

Academic Departments Pathology -Associate Professor (Clinical)
Board Certification
American Board of Pathology (Anatomic & Clinical)
American Board of Pathology (Sub: Hematopathology)

Education history

Fellowship Hematopathology - University of Utah School of Medicine Fellow
Chief Resident Pathology - State University of New York Downstate Health Science Center at Brooklyn Chief Resident
Residency Anatomical/Clinical Pathology - State University of New York Downstate Health Science Center at Brooklyn Resident
Doctoral Training Pathology - Perm State Medical Academy/St. Petersburg Academy of Postgraduate Medical Education, Ph.D.
Residency Pathology - Perm State Medical Academy Resident
Professional Medical Medicine - Perm State Medical Academy M.D.

Selected Publications

Journal Article

  1. Siebenhaar F, Broesby-Olsen S, Castells M, George TI, Livideanu CB, Alvarez-Twose I, Panse J, Barete S, Reiter A, Dybedal I, Akin C, Van Daele P, Radia DH, Cerquozzi S, Ustun C, Sabato V, Gotlib J, Rafferty M, DeAngelo DJ, Schafhausen P, Ungerstedt J, Ogbogu PU, Florell S, Wada DA, Rets A, Lin HM, Bidollari I, Hong J, Shaheen D, Lampson B, Hartmann K (2026). Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER study. J Am Acad Dermatol.
  2. Shean RC, Agarwal A, Rets AV (2025). Unstable Hemoglobin, a Rare but Significant Cause of Hemolytic Anemia: Recognition of Peripheral Smear Findings Is Crucial for Diagnosis. Int J Lab Hematol, 48(2), 237-239.
  3. Shean R, Deshmukh N, Palmer M, Agarwal A, Rets A (2025). Utility of Molecular Sequencing and Hematologic Parameters for Diagnosis of α-Thalassemia: A Perspective of the National Reference Laboratory. Hemoglobin, 1-7.
  4. Maccio U, Rets A, Grosse C, Ferguson NA, Langer R, Bhler MM, Gallo A, Witzel I, Beham-Schmid C, Wieler J, Orsaria M, Varga Z (2025). Clinical and pathological features of lymphomas in the breast: a comprehensive multicentric study. Sci Rep, 15(1), 29032.
  5. Shestakova A, Rets AV, Menon M (2025). Autoimmune Hepatobiliary Disease and Cryoglobulins in Peripheral Blood. Am J Hematol, 100(12), 2373-2374.
  6. Shean RC, Hellwig S, Saadalla A, George TI, Rets AV (2025). High-sensitivity KIT D816V variation analysis by droplet digital polymerase chain reaction: The reference laboratory perspective. Am J Clin Pathol.
  7. Zhukovsky S, Rets A, Braaten T, Patel AB (2024). VEXAS without vacuoles: Linking genotype to phenotype. EJHaem, 5(5), 981-986.
  8. Vardell VA, Ose J, Rets AV, Tantravahi SK, Patel AB (2024). Chronic Myelomonocytic Leukemia and Atypical Chronic Myeloid Leukemia: A National Analysis. Clin Lymphoma Myeloma Leuk, 24(12), 843-851.
  9. Rets AV, George TI (2024). How I diagnose systemic mastocytosis. Am J Clin Pathol.
  10. Agarwal AM, McMurty V, Clayton AL, Bolia A, Reading NS, Mani C, Patel JL, Rets A (2023). Clinical utility of targeted next-generation sequencing panel in routine diagnosis of hereditary hemolytic anemia: A national reference laboratory experience. Eur J Haematol, 110(6), 688-695.
  11. Liew M, Rowe L, Moore K, Aston E, OBrien K, Longhurst M, Kenney J, Priest M, Zhou W, Wilcock D, Rets A, Miles R (2023). Validation of MYC and BCL6 rapid break apart digital fluorescence in situ hybridization assays for clinical use. Int J Clin Exp Pathol, 16(4), 76-85.
  12. Ramia de Cap M, Wu LP, Hirt C, Pihan GA, Patel SS, Tam W, Bueso-Ramos CE, Kanagal-Shamanna R, Raess PW, Siddon A, Narayanan D, Morgan EA, Pinkus GS, Mason EF, Hsi ED, Rogers HJ, Toth L, Foucar K, Hurwitz SN, Bagg A, Rets A, George TI, Orazi A, Arber DA, Hasserjian RP, Weinberg OK, Bone Marrow Pathology Group (2023). Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group. Leuk Lymphoma, 1-9.
  13. Al-Ghamdi YA, Lake J, Bagg A, Thakral B, Wang SA, Bueso-Ramos C, Masarova L, Verstovsek S, Rogers HJ, Hsi ED, Gralewski JH, Chabot-Richards D, George TI, Rets A, Hasserjian RP, Weinberg OK, Parilla M, Arber DA, Padilla O, Orazi A, Tam W (2023). Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group Study. Mod Pathol, 36(3), 100016.
  14. Maccio U, Rets AV (2022). Lymphoid aggregates in bone marrow: a diagnostic pitfall. J Clin Pathol, 75(12), 807-814.
  15. Agarwal AM, Rets A (2021). Laboratory approach to investigation of anemia in pregnancy. Int J Lab Hematol, 43 Suppl 1, 65-70.
  16. Rets AV, Reading NS, Agarwal AM (2020). δ-Globin Chain Variants Associated with Decreased Hb A2 Levels: A National Reference Laboratory Experience. Hemoglobin, 44(6), 438-441.
  17. Agarwal AM, Rets A (2020). Laboratory approach to investigation of anemia with a focus on pyruvate kinase deficiency. Int J Lab Hematol, 42 Suppl 1, 107-112.
  18. Rets A, Clayton AL, Christensen RD, Agarwal AM (2019). Molecular diagnostic update in hereditary hemolytic anemia and neonatal hyperbilirubinemia. Int J Lab Hematol, 41 Suppl 1, 95-101.
  19. Toydemir RM, Rets AV, Hussong JW, Atanackovic D, Salama ME (2018). Immunophenotypic and cytogenetic evolution patterns of the neoplastic plasma cells in multiple myeloma relapsed after stem cell transplant. J Hematop, 11(3), 75-80.
  20. Gangaraju R, Rets A, Smock KJ, Heikal NM (2017). Rare complication of treated immune thrombocytopenia. Am J Hematol, 92(11), 1262-1266.
  21. Harper A, Lu C, Sun Y, Garcia R, Rets A, Alexis H, Saad H, Eid I, Harris L, Marshall B, Tafani E, Pincus MR (2015). Reproducibility of Serum Potassium Values in Serum From Blood Samples Stored for Increasing Times Prior to Centrifugation and Analysis. J Clin Lab Anal, 30(3), 244-7.
  22. Rets AV, Gottesman SR (2014). Nodular Lymphocyte Predominant Hodgkin Lymphoma versus T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Diagnostic Challenge. Case Rep Pathol, 2014, 956217.
  23. Rets A, Gupta R, Haseeb MA (2013). Determinants of reactivation of inapparent Strongyloides stercoralis infection in patients hospitalized for unrelated admitting diagnosis. Eur J Gastroenterol Hepatol, 25(11), 1279-85.
  24. Qin J, Wang H, Rets A, Harari S, Alexis H, Eid I, Pincus MR (2012). Stability of BUN and creatinine determinations on the Siemens Advia 1800 analyzer. J Clin Lab Anal, 27(6), 435-7.
  25. Friend GG, Kruchkov AN, Rets AV (2004). Comparative Characteristic of Axillary Lymph Nodes in Breast Carcinoma Patients with and without Radiotherapy. (3), 56-8.
  26. Patrikeev IA, Kruchkov AN, Friend GG, Yurlov RA, Rets AV (2004). Usage of wavelet filtration for assessment of nuclear pleomorphism in invasive ductal carcinoma of the breast. 8(4), 91-6.

Review

  1. Rets A, George TI (2025). Diagnosing Systemic Mastocytosis: State of the Art. [Review]. Int J Lab Hematol.
  2. Shean RC, Rets AV (2025). Digital Pathology in Hematopathology: From Vision to Deployment. [Review]. Int J Lab Hematol.
  3. Shestakova G, Edgar NU, Rets AV (2025). Common Hematologic Emergencies-Acute Promyelocytic Leukemia and Microangiopathic Hemolytic Anemias-A Pivotal Role of Clinical Laboratory. [Review]. Int J Lab Hematol.
  4. Madigan LM, Boggs NA, Rets AV, Gru AA, Tashi T, Wada DA, Florell SR, Carter MC (2025). Mastocytosis in the Skin: Approach to Diagnosis, Evaluation, and Management in Adult and Pediatric Patients. [Review]. Am J Clin Dermatol, 26(4), 499-510.
  5. Genzen JR, Miller LJ, Rets AV, Affolter KE (2024). Laboratory-developed tests and in vitro diagnostics: A regulatory overview for anatomic pathology. [Review]. Am J Clin Pathol, 163(5), 730-743.
  6. Shean RC, Williams MC, Rets AV (2024). Advances in Hematology Analyzers Technology. [Review]. Clin Lab Med, 44(3), 377-386.
  7. Agarwal AM, Rets AV (2024). Advances in Hemoglobinopathies and Thalassemia Evaluation. [Review]. Clin Lab Med, 44(3), 441-453.
  8. Dadelahi A, Jackson T, Agarwal AM, Lin L, Rets AV, Ng DP (2024). Applications of Flow Cytometry in Diagnosis and Evaluation of Red Blood Cell Disorders. [Review]. Clin Lab Med, 44(3), 495-509.
  9. Maccio U, Gianolio A, Rets AV (2023). Granulomas in bone marrow biopsies: clinicopathological significance and new perspectives. [Review]. J Clin Pathol.
  10. Agarwal AM, Rets AV (2023). Molecular diagnosis of hereditary hemolytic anemias: Recent updates. [Review]. Int J Lab Hematol, 45 Suppl 2, 79-86.

Book Chapter

  1. Rets AV, Agarwal AM (2024). Chapter 8: Using Targeted Genetic Panels to Find the Causes of Neonatal hemolytic anemia. In Robin Ohls, Akhil Maheshwari and Robert Christensen (Eds.), Neonatology Questions and Controversies: Hematology and Transfusion Medicine (4th, pp. 91-102). Elsevier.
  2. Rets A (2008). Death. Necrosis. Apoptosis. Degeneration. In General Pathology Manual. Perm, Russia: Perm State Medical Academy.
  3. Friend GG, Kruchkov AN, Rets AV (2004). Morphological Diagnostics of Radiogenic Changes in Lymph Nodes Manual. Perm, Russia: Perm State Medical Academy.
  4. Agarwal A, Rets A (). Disorders of hemoglobin synthesis, thalassemias and structural hemoglobinopathies. In Maria A. Proytcheva (Ed.), Diagnostic Pediatric Hematopathology. Cambridge University Press.

Case Report

  1. Simpson SJ, Lim MY, George TI, Rets A (2021). 36-year-old male with X-linked congenital sideroblastic anemia presenting as chronic microcytic anemia with iron overload. Int J Lab Hematol, 44(1), 69-71.
  2. Rets AV, Eid I, Lutwick L, Pincus MR (2012). Parotid gland abscess caused by Haemophilus paraphrophilus: a case report. Ann Clin Lab Sci, 42(4), 422-3.

Letter

  1. Tantravahi SK, Ellero AA, Patel AB, Parsegov B, Walker CJ, Yap JT, Boucher KM, Rets AV, Prchal JT, Deininger MW (2026). Single agent selinexor is active in patients with myelofibrosis refractory or intolerant to JAK inhibitors. [Letter to the editor]. Blood Cancer J, 16(1).
  2. Agarwal AM, Rets A, Mani C (2025). Novel Mutations in SUPT5H Gene Associated With Beta-Thalassemia Phenotype. [Letter to the editor]. Int J Lab Hematol, 47(3), 552-554.
  3. Osman AEG, Rets A, Patel AB (2024). KRAS mutations, autoimmunity and female sex in chronic myelomonocytic leukemia. [Letter to the editor]. Leuk Res, 138, 107466.
  4. Meznarich JA, Rets A, Agarwal AM, Christensen RD, Reading NS, Kuypers FA, Prchal JT (2021). Novel, de novo, beta-globin variant with decreased oxygen affinity (HBB:c.317T>A, "Hemoglobin St. George") in a healthy child with low oxygen saturations and anemia. [Letter to the editor]. Am J Hematol, 96(12), E448-E450.

Abstract

  1. Stivers N, Rets AV (2020). Case of T-cell large granular lymphocytic leukemia with clonal drift and immunophenotype normalization. [Abstract]. 144(9s1), e65.
  2. Mohlman J, Rets AV (2019). Fibrin-Associated Diffuse Large B-Cell Lymphoma Occurring as a Pararenal Pseudocyst [Abstract]. 152(S1), S105.
  3. McMurtry V, Rets AV (2019). Comparison of MYC Break-Apart and IGH/MYC Dual-Fusion Probe Sensitivity for Detection of MYC Rearrangements in Large B-Cell Lymphomas [Abstract]. 143(9), e68.
  4. Rets AV, Toydemir RM, Hussong JW, Salama ME (2016). Immunophenotypic and cytogenetic evolution pattern of the neoplastic cells in relapsed multiple myeloma after stem cell transplant [Abstract]. 29(S2).
  5. Tripp SR, Rets AV, Tsewang T, Salama ME (2016). Immunohistochemical detection of Calreticulin mutations in bone marrow biopsy samples from patients with myeloproliferative neoplasms. [Abstract].
  6. Rets AV, Yaoping Z, Gottesman RS (2015). Monotypic B-Cell Population and Chromosomal Aberration in Histologically Benign Lymph Node [Abstract]. 139(10), e53.
  7. Rets AV, Verma V, Gottesman SR (2014). Aggressive marginal zone lymphoma [Abstract]. Archives of Pathology & Laboratory Medicine, 139(9), e2-e183.
  8. Rets AV, Gupta R, Rao S (2013). Rare Variant Translocation in a Pediatric Case of Chronic Myelogenous Leukemia [Abstract]. Arch Pathol La b Med, 137(10), 1363.
  9. Kruchkov AN, Rets AV (2004). Mast Cells in Regional Lymph Nodes in Radiation-treated Breast Carcinoma [Abstract]. Organization of Pathology Service, Diagnostics and Expertise, (6), 195-200.
  10. Friend GG, Kruchkov AN, Rets AV (2004). Morphologic Characteristic of Axillary Lymph Node Sinuses in Radiation-treated Breast Carcinoma [Abstract]. Organization of Pathology Service, Diagnostics and Expertise, Magnitogorsk, (6), 236-241.
  11. Rets AV (2003). Radiogenic Changes in the Axillary Lymph Nodes Capsule in Breast Carcinoma [Abstract]. New Directions and Developments in Oncomorphology, (30), 51-53.
  12. Kruchkov AN, Rets AV (2003). Quantitative Patterns in Tumor Cell Apoptosis in Different Histological Variants of Breast Carcinoma [Abstract]. New Directions and Developments in Oncomorphology, (30), 25-26.
  13. Anisimov GV, Kruchkov AN, Rets AV (2003). Mucoid degeneration of stroma in patients with breast carcinoma. [Abstract]. New Directions and Developments in Oncomorphology, (30), 27-28.
  14. Friend GG, Kruchkov AN, Patrikeev IA, Rets AV, Urlov RA (2003). Methods of Tumor Cell Nuclear Polymorphism Computer-based Evaluation [Abstract]. New Directions and Developments in Oncomorphology, (30), 40-42.
  15. Rets AV (2002). Radiogenic Apoptosis of Breast Carcinoma Cells in Primary Tumor and Regional Metastases [Abstract]. Actual Problems of Theoretical, Experimental and Clinical Medicine, (36), 129-30.
  16. George TI, Karner KH, Moser, KI, Rets A, Reiter A, Radia DH, Deininger M, Lin HM, Dimitrijevi S, Cossetti C, DeAngelo DJ (). Responses to Avapritinib in patients with advanced systemic mastocytosis: histopathologic analyses from Explorer and Pathfinder clinical studies. [Abstract]. (Epub ahead of print)

Other

  1. Madigan LM, Boggs NA, Rets AV, Gru AA, Tashi T, Wada DA, Florell SR, Carter MC (2025). Correction to: Mastocytosis in the Skin: Approach to Diagnosis, Evaluation, and Management in Adult and Pediatric Patients. Am J Clin Dermatol (26(5), p. 851). New Zealand.

Video/Film/CD/Web/Podcast

  1. N Leonard (2021). Soft Tissue Sarcoma for ARUP Consult [Web]. ARUP Consult.
  2. Rets AV (2020). 32-year old man with chronic microcytic anemia/ Hb Constant Spring and Hb H disease [Web]. International Society for Laboratory Hematology: E-learning interactive case studies: International Society for Laboratory Hematology.
  3. Rets AV (2019). 32-year-old man with chronic microcytic anemia [J Digit Imaging]. International Society for Laboratory Hematology: E-learning interactive case studies.

Patent

  1. Kruchkov AN, Friend GG, Rets AV (2005). Method of computerized evaluation of nuclear pleomorphism of tumor cells. Intellectual product patent by Federal State Unitarian Institution “Russian Scientific and Technical Information Center”. U.S. Patent No. 73200500011. Washington, D.C.:U.S. Patent and Trademark Office.